Japan, Sept. 28 -- AKESO PHARMACEUTICALS INC has got intellectual property rights for 'ANTI-CTLA4/ANTI-PD-1 BISPECIFIC ANTIBODIES AND USES THEREOF.' Other related details are as follows:

Application Number: JP,2025-047199

Category (FI): A61K39/395@U,C07K16/46,A61K49/00,A61K51/10,C12N15/63@Z,C12N1/15,C12N1/19,C12N1/21,C12N5/10,A61P35/00,A61P7/06,A61K39/395@N,C12N15/62@Z,C12N15/13,C07K16/28,C12P21/08,A61K31/47,A61K45/00

Stage: Grant (IP right granted following substantive examination.)

Filing Date: March 21, 2025

Publication Date: July 8, 2025

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication....